LBG
ABBV icon

Lloyds Banking Group’s AbbVie ABBV Stock Holding History

Lloyds Banking Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-17,117
Closed -$988K – 58
2014
Q3 		$988K Buy
17,117
+4,325
+34% +$240K 0.27% 101
2014
Q2 		$721K Sell
12,792
-681,285
-98% -$35.7M 0.17% 152
2014
Q1 		$35.7M Sell
694,077
-24,320
-3% -$1.23M 0.32% 93
2013
Q4 		$37.9M Buy
718,397
+42,315
+6% +$2.08M 0.34% 76
2013
Q3 		$30.2M Buy
676,082
+83,099
+14% +$3.68M 0.31% 89
2013
Q2 		$24.5M Buy
+592,983
New +$25.9M 0.26% 100

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Lloyds Banking Group's ABBV Position: Q4 2014 in Review

Lloyds Banking Group sold out of AbbVie (ABBV) in Q4 2014, closing a stake of 17,117 shares — an estimated $988K sold.

Lloyds Banking Group first reported a position in ABBV in Q2 2013 and held it in 6 quarters. The position peaked at $37.9M in Q4 2013. 1,606 funds tracked by Wall St. Rank hold ABBV as of Q4 2014.

  • Lloyds Banking Group reported no remaining AbbVie position as of Q4 2014 after selling out during the quarter.
  • Lloyds Banking Group sold 17,117 AbbVie shares in Q4 2014, an estimated $988K.
  • Lloyds Banking Group first reported a position in AbbVie in Q2 2013 and held it in 6 quarters.
  • Lloyds Banking Group's AbbVie position peaked at $37.9M in Q4 2013.
  • 1,606 funds tracked by Wall St. Rank held AbbVie as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.